Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 841 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cabaletta Bio, Inc.
Market Cap
$322.85M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$321.85M
Operating Margin
9.36%
TTM Avg
0.56%
3Y Avg
-8.17%
5Y Avg
-15.92%
Market Cap
$324.76M
Operating Margin
-188.25%
TTM Avg
-178.83%
3Y Avg
-158.00%
5Y Avg
-158.00%
Market Cap
$320.29M
Operating Margin
-65.36%
TTM Avg
-64.13%
3Y Avg
-75.36%
5Y Avg
-72.00%
Market Cap
$319.65M
Operating Margin
-59.40%
TTM Avg
-73.74%
3Y Avg
-78.11%
5Y Avg
-79.89%
Market Cap
$318.76M
Operating Margin
-18.00%
TTM Avg
-67.22%
3Y Avg
-104.89%
5Y Avg
-90.63%
Market Cap
$313.46M
Operating Margin
-290.68%
TTM Avg
-313.41%
3Y Avg
-428.31%
5Y Avg
-345.79%
Market Cap
$302.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6360.33%
5Y Avg
-12157.15%
Market Cap
$301.90M
Operating Margin
-144.71%
TTM Avg
-144.71%
3Y Avg
-144.71%
5Y Avg
-144.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | $322.85M | 0.00% | 0.00% | 0.00% | 0.00% |
| Sanara MedTech Inc. (SMTI)vs › | $321.85M | 9.36% | 0.56% | -8.17% | -15.92% |
| CapsoVision, Inc. (CV)vs › | $324.76M | -188.25% | -178.83% | -158.00% | -158.00% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $320.29M | -65.36% | -64.13% | -75.36% | -72.00% |
| Avita Medical Inc. (RCEL)vs › | $319.65M | -59.40% | -73.74% | -78.11% | -79.89% |
| Agenus Inc. (AGEN)vs › | $318.76M | -18.00% | -67.22% | -104.89% | -90.63% |
| C4 Therapeutics, Inc. (CCCC)vs › | $313.46M | -290.68% | -313.41% | -428.31% | -345.79% |
| Benitec Biopharma Inc. (BNTC)vs › | $302.37M | 0.00% | 0.00% | -6360.33% | -12157.15% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $301.90M | -144.71% | -144.71% | -144.71% | -144.71% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.27M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
